Fig. 3
From: High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis
TWEAK serum levels according to presence of disease activity. a The serum levels of soluble TWEAK were significantly increased during relapses, compared to time periods without any relapse (respectively 935 ± 489 pg/mL and 611 ± 292 pg/mL (p = 0.0005)); b The same profile was shown with MRI activity at baseline with serum TWEAK levels of 1421 ± 657 pg/mL in patients who present gadolinium enhancement compared to 975 ± 382 pg/mL in case of absence of gadolinium enhancement (p = 0.02)